Mahesh Prasad
Mahesh Prasad has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Anant Prakash Pandey
Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119
4 shared publications - Antesh Kumar Jha
Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119
4 shared publications - Shashi Shankar
Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119
4 shared publications - Shiv Kumar Srivastava
Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119
4 shared publications - Abhishek Singh
Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119
3 shared publications Alok C
1 shared publication
Latest Publications
- Open Access
- 15 June 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (6) , 251-262
Present Developments and Prospects for Natural Polymer-Based Drug Delivery Systems and Patient-Friendly Formulations
Natural polymer-based drug delivery systems have gained significant attention in pharmaceutical research due to their biocompatibility, biodegradability, non-toxicity, affordability, and eco-friendly nature. Derived from plant, animal, microbial, and marine sources, these polymers play an important role in developing advanced and patient-friendly formulations. Commonly used natural polymers include sodium alginate, pectin, guar gum, xanthan gum, gelatin, chitosan, starch, and psyllium husk. Their unique properties such as swelling, gel formation, mucoadhesion, viscosity enhancement, and controlled drug release make them suitable for various drug delivery systems including fast-dissolving tablets, sustained-release formulations, hydrogels, nanoparticles, microbeads, and in situ gels. These systems improve therapeutic efficacy, enhance drug stability, reduce side effects, and increase patient compliance, especially in pediatric, geriatric, and dysphagic patients. The uses of natural polymers in pharmaceutical sciences have been further increased by recent developments in nanotechnology, smart hydrogels, mucoadhesive systems, targeted drug delivery, AI-assisted formulation optimization, and 3D printing. Their industrial use is nevertheless restricted by problems such batch-to-batch variability, microbiological contamination, inadequate mechanical strength, stability concerns, and lack of standardization, despite their many benefits. Therefore, maintaining product safety and reproducibility requires appropriate purification, quality control, and regulatory review. Future projections show that natural polymers will be increasingly integrated with intelligent drug delivery systems, green pharmaceutical technology, and personalized treatment. All things considered, natural polymers present a promising platform for the creation of pharmaceutical formulations that are patient-centered, safe, and sustainable and have a great deal of potential for therapeutic uses in the future. Keywords: Drug delivery techniques; natural polymers; Biodegradable polymers; patient-friendly formulations; Smart hydrogels and regulated medication release
- 15 June 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (6) , 251-262
Open AccessPresent Developments and Prospects for Natural Polymer-Based Drug Delivery Systems and Patient-Friendly Formulations
Natural polymer-based drug delivery systems have gained significant attention in pharmaceutical research due to their biocompatibility, biodegradability, non-toxicity, affordability, and eco-friendly nature. Derived from plant, animal, microbial, and marine sources, these polymers play an important role in developing advanced and patient-friendly formulations. Commonly used natural polymers include sodium alginate, pectin, guar gum, xanthan gum, gelatin, chitosan, starch, and psyllium husk. Their unique properties such as swelling, gel formation, mucoadhesion, viscosity enhancement, and controlled drug release make them suitable for various drug delivery systems including fast-dissolving tablets, sustained-release formulations, hydrogels, nanoparticles, microbeads, and in situ gels. These systems improve therapeutic efficacy, enhance drug stability, reduce side effects, and increase patient compliance, especially in pediatric, geriatric, and dysphagic patients. The uses of natural polymers in pharmaceutical sciences have been further increased by recent developments in nanotechnology, smart hydrogels, mucoadhesive systems, targeted drug delivery, AI-assisted formulation optimization, and 3D printing. Their industrial use is nevertheless restricted by problems such batch-to-batch variability, microbiological contamination, inadequate mechanical strength, stability concerns, and lack of standardization, despite their many benefits. Therefore, maintaining product safety and reproducibility requires appropriate purification, quality control, and regulatory review. Future projections show that natural polymers will be increasingly integrated with intelligent drug delivery systems, green pharmaceutical technology, and personalized treatment. All things considered, natural polymers present a promising platform for the creation of pharmaceutical formulations that are patient-centered, safe, and sustainable and have a great deal of potential for therapeutic uses in the future. Keywords: Drug delivery techniques; natural polymers; Biodegradable polymers; patient-friendly formulations; Smart hydrogels and regulated medication release
- Open Access
- 15 April 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (4) , 165-176
A Thorough Analysis of Natural Polymers as Functional Excipients in Contemporary Pharmaceutical Formulations
Natural polymers' innate biocompatibility, biodegradability, and environmental friendliness have made them attractive functional excipients in contemporary pharmaceutical formulations. This study emphasizes the importance of natural polymers-such as starch, cellulose, alginate, chitosan, gelatin, and xanthan gum-derived from plant, animal, and microbial sources in the creation of cutting-edge drug delivery methods. These polymers have a variety of physicochemical characteristics, including swelling, viscosity, gel-forming capacity, and mucoadhesion, all of which are essential for regulating drug release, boosting stability, and increasing bioavailability. Natural polymers are appealing substitutes for synthetic excipients in pharmaceutical applications because they provide benefits such lower toxicity, sustainability, and cost-effectiveness. The categorization, origins, and functional roles of natural polymers in biological, pharmacological, and environmental applications are also covered in the review. Their use in targeted delivery, hydrogels, nanoparticles, controlled and sustained drug delivery systems, and gene delivery systems is highlighted. Additionally, recent advancements including the invention of stimuli-responsive polymers, chemical modification, and the integration of nanotechnology have significantly enhanced their functionality and broadened their applications. Despite its advantages, challenges like unpredictability, microbial contamination, and regulatory difficulties require standardization and advanced processing techniques. All things considered, natural polymers provide a versatile and durable foundation for the development of innovative drug delivery systems, improving patient compliance and therapeutic outcomes in modern pharmaceutical sciences. Keywords: Mucoadhesion, biocompatibility, controlled drug delivery, pharmaceutical excipients, natural polymers, and biodegradability
- 15 April 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (4) , 165-176
Open AccessA Thorough Analysis of Natural Polymers as Functional Excipients in Contemporary Pharmaceutical Formulations
Natural polymers' innate biocompatibility, biodegradability, and environmental friendliness have made them attractive functional excipients in contemporary pharmaceutical formulations. This study emphasizes the importance of natural polymers-such as starch, cellulose, alginate, chitosan, gelatin, and xanthan gum-derived from plant, animal, and microbial sources in the creation of cutting-edge drug delivery methods. These polymers have a variety of physicochemical characteristics, including swelling, viscosity, gel-forming capacity, and mucoadhesion, all of which are essential for regulating drug release, boosting stability, and increasing bioavailability. Natural polymers are appealing substitutes for synthetic excipients in pharmaceutical applications because they provide benefits such lower toxicity, sustainability, and cost-effectiveness. The categorization, origins, and functional roles of natural polymers in biological, pharmacological, and environmental applications are also covered in the review. Their use in targeted delivery, hydrogels, nanoparticles, controlled and sustained drug delivery systems, and gene delivery systems is highlighted. Additionally, recent advancements including the invention of stimuli-responsive polymers, chemical modification, and the integration of nanotechnology have significantly enhanced their functionality and broadened their applications. Despite its advantages, challenges like unpredictability, microbial contamination, and regulatory difficulties require standardization and advanced processing techniques. All things considered, natural polymers provide a versatile and durable foundation for the development of innovative drug delivery systems, improving patient compliance and therapeutic outcomes in modern pharmaceutical sciences. Keywords: Mucoadhesion, biocompatibility, controlled drug delivery, pharmaceutical excipients, natural polymers, and biodegradability
- Open Access
- 15 March 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (3) , 180-191
Alginate-Based Hydrogels and Particulate Systems: Preparation Techniques, Adaptations, and Utilizations in Pharmaceutical Delivery and Biomedical Research
Alginate, a naturally derived anionic polysaccharide largely extracted from brown algae, has become a versatile biomaterial for pharmaceutical and biomedical applications due to its exceptional biocompatibility, biodegradability, non-toxicity, and gentle gelation qualities. The peculiar block-copolymeric arrangement of alginate, composed of β-D-mannuronic acid (M) and α-L-guluronic acid (G) residues, governs its physicochemical, mechanical, and biological features via modifications in molecular weight, M/G ratio, and block distribution. This review critically analyzes recent developments in alginate-based hydrogels and particulate systems, focusing on extraction methods, structural characterization, and modification strategies designed to address inherent limitations, including inadequate mechanical strength, uncontrolled degradation, and restricted bioactivity. The impacts of ionic and covalent crosslinking techniques, including egg-box gelation, photo-crosslinking, dual-network formation, and thermo-responsive systems, on rheology, stability, swelling, and controlled drug release behavior are discussed. The paper highlights the expanding biological applications of alginate systems in regenerative medicine, tissue engineering, wound healing, controlled and targeted drug delivery, and cell encapsulation. Special emphasis is placed on in vivo efficacy, immunogenicity, toxicity assessments, and regulatory compliance, comprising FDA and EU approvals. We also look at new developments including injectable hydrogels, hybrid scaffolds, and stimuli-responsive alginate composites. Alginate-based platforms comprise a promising category of biomaterials, and continuous developments in molecular modification and crosslinking technologies are projected to boost their translational potential in next-generation pharmacological and biological applications. Keywords: Alginate hydrogels; Egg-box cross-linking; Bio-polymeric frameworks; Biomedical materials
- 15 March 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (3) , 180-191
Open AccessAlginate-Based Hydrogels and Particulate Systems: Preparation Techniques, Adaptations, and Utilizations in Pharmaceutical Delivery and Biomedical Research
Alginate, a naturally derived anionic polysaccharide largely extracted from brown algae, has become a versatile biomaterial for pharmaceutical and biomedical applications due to its exceptional biocompatibility, biodegradability, non-toxicity, and gentle gelation qualities. The peculiar block-copolymeric arrangement of alginate, composed of β-D-mannuronic acid (M) and α-L-guluronic acid (G) residues, governs its physicochemical, mechanical, and biological features via modifications in molecular weight, M/G ratio, and block distribution. This review critically analyzes recent developments in alginate-based hydrogels and particulate systems, focusing on extraction methods, structural characterization, and modification strategies designed to address inherent limitations, including inadequate mechanical strength, uncontrolled degradation, and restricted bioactivity. The impacts of ionic and covalent crosslinking techniques, including egg-box gelation, photo-crosslinking, dual-network formation, and thermo-responsive systems, on rheology, stability, swelling, and controlled drug release behavior are discussed. The paper highlights the expanding biological applications of alginate systems in regenerative medicine, tissue engineering, wound healing, controlled and targeted drug delivery, and cell encapsulation. Special emphasis is placed on in vivo efficacy, immunogenicity, toxicity assessments, and regulatory compliance, comprising FDA and EU approvals. We also look at new developments including injectable hydrogels, hybrid scaffolds, and stimuli-responsive alginate composites. Alginate-based platforms comprise a promising category of biomaterials, and continuous developments in molecular modification and crosslinking technologies are projected to boost their translational potential in next-generation pharmacological and biological applications. Keywords: Alginate hydrogels; Egg-box cross-linking; Bio-polymeric frameworks; Biomedical materials
- Open Access
- 15 February 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (2) , 29-40
From Molecules to Medicine: Nanotechnology Transforming Modern Therapeutics
Nanotechnology, the manipulation of matter at the molecular and nanometer scale, has emerged as a transformative force across multiple disciplines, particularly in medicine. Its unique physicochemical properties allow the design of nanoscale materials that improve diagnostics, therapeutics, and drug delivery systems. Nanomedicine, a pivotal branch of nanotechnology, focuses on precise targeting of drugs, controlled release, enhanced bioavailability, and improved imaging, ultimately enhancing disease management and patient outcomes. Over the past few decades, the rapid growth of research has facilitated the commercialization of various nanoparticle-based products, with drug delivery platforms comprising the largest market share. Nanoparticles, including liposomes, polymeric micelles, dendrimers, quantum dots, carbon nanotubes, nanoshells, nanobubbles, and solid lipid nanoparticles, offer distinct advantages such as biocompatibility, enhanced cellular uptake, targeted tissue accumulation, and the ability to cross biological barriers like the blood–brain barrier. Various fabrication methods-such as solvent evaporation, emulsification, ionic gelation, nano-spray drying, and supercritical fluid technology-allow precise control over particle size, surface characteristics, and drug encapsulation, enabling customization for specific therapeutic needs. Nanoparticle-based systems have demonstrated significant potential in treating cancer, neurodegenerative disorders, infectious diseases, chronic kidney disease, and in vaccine delivery, including COVID-19. Keywords: Nanomedicine, Nanoparticles, Targeted drug delivery, Controlled release, Biocompatibility, Therapeutics
- 15 February 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (2) , 29-40
Open AccessFrom Molecules to Medicine: Nanotechnology Transforming Modern Therapeutics
Nanotechnology, the manipulation of matter at the molecular and nanometer scale, has emerged as a transformative force across multiple disciplines, particularly in medicine. Its unique physicochemical properties allow the design of nanoscale materials that improve diagnostics, therapeutics, and drug delivery systems. Nanomedicine, a pivotal branch of nanotechnology, focuses on precise targeting of drugs, controlled release, enhanced bioavailability, and improved imaging, ultimately enhancing disease management and patient outcomes. Over the past few decades, the rapid growth of research has facilitated the commercialization of various nanoparticle-based products, with drug delivery platforms comprising the largest market share. Nanoparticles, including liposomes, polymeric micelles, dendrimers, quantum dots, carbon nanotubes, nanoshells, nanobubbles, and solid lipid nanoparticles, offer distinct advantages such as biocompatibility, enhanced cellular uptake, targeted tissue accumulation, and the ability to cross biological barriers like the blood–brain barrier. Various fabrication methods-such as solvent evaporation, emulsification, ionic gelation, nano-spray drying, and supercritical fluid technology-allow precise control over particle size, surface characteristics, and drug encapsulation, enabling customization for specific therapeutic needs. Nanoparticle-based systems have demonstrated significant potential in treating cancer, neurodegenerative disorders, infectious diseases, chronic kidney disease, and in vaccine delivery, including COVID-19. Keywords: Nanomedicine, Nanoparticles, Targeted drug delivery, Controlled release, Biocompatibility, Therapeutics
- Open Access
- 31 December 2022
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 25 (4) , 369-381
Modulation of Inula racemosa Hook Extract on Cardioprotection by Ischemic Preconditioning in Hyperlipidaemic Rats
Arun Kumar Tiwari, Pushpraj S Gupta, Mahesh Prasad, Paraman Malairajan. J Pharmacopuncture 2022;25:369-81. https://doi.org/10.3831/KPI.2022.25.4.369
- 31 December 2022
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 25 (4) , 369-381
Open AccessModulation of Inula racemosa Hook Extract on Cardioprotection by Ischemic Preconditioning in Hyperlipidaemic Rats
Arun Kumar Tiwari, Pushpraj S Gupta, Mahesh Prasad, Paraman Malairajan. J Pharmacopuncture 2022;25:369-81. https://doi.org/10.3831/KPI.2022.25.4.369
- Open Access
- 12 January 2022
- Published by Science and Education Publishing Co., Ltd. in Applied Ecology and Environmental Sciences
- Vol. 10 (6) , 346-359
Plant Macrofossils from Churia Formation (Miocene) of Koilabas Area in the Himalayan Foot Hills of Western Nepal and their Palaeoclimatic Consideration
Palaeobotanical study on the plant macrofossils from Lower and Middle Churia Formation (Miocene) of Koilabas area, western Nepal has revealed the presence of 116 species belonging to 83 genera of 33 angiospermous families. They are mainly based on leaf-impressions and a fruit and seed. The family Fabaceae is the most dominant family represented by 21 species in this assemblage followed by Annonaceae (10 species), Dipterocarpaceae, Sapindaceae and Anacardiaceae (6 species) and Combretaceae, Rubiaceae, and Moraceae (5 species). Fabaceae which appeared in Upper Paleocene became a major constituent of the evergreen forest during Miocene times all along the Himalayan foot hills. The predominance of evergreen and moist deciduous taxa in this fossil assemblage indicates the prevalence of tropical warm humid climate with plenty of rain fall during the Miocene. The present-day distribution of comparable modern species of all the fossils recovered from Koilabas area indicates that they are mostly known to occur in South east Asia, Indo-Malayan and North-east Indian regions, wherever favorable climatic conditions exist. Most of the taxa represented in the fossil assemblage do not occur in the Koilabas area or all along the Himalayan foot-hills of both India and Nepal. This obviously indicates that changes in the climate must have taken place after the deposition of Siwalik sediments in the Koilabas area. Study of the structural features of fossil leaf-impressions suggests that the Koilabas area in the Himalayan foot-hills of western Nepal enjoyed a tropical climate along with plenty of rainfall during the Miocene times. Coexistence /Nearest Living Relative (NLR) method further suggests that the area enjoyed a tropical climate with the Mean Annual Temperature (MAT) 23-30°C and Mean Annual Precipitation (MAP) 2400-3600 mm) during the Miocene.
- 12 January 2022
- Published by Science and Education Publishing Co., Ltd. in Applied Ecology and Environmental Sciences
- Vol. 10 (6) , 346-359
Open AccessPlant Macrofossils from Churia Formation (Miocene) of Koilabas Area in the Himalayan Foot Hills of Western Nepal and their Palaeoclimatic Consideration
Palaeobotanical study on the plant macrofossils from Lower and Middle Churia Formation (Miocene) of Koilabas area, western Nepal has revealed the presence of 116 species belonging to 83 genera of 33 angiospermous families. They are mainly based on leaf-impressions and a fruit and seed. The family Fabaceae is the most dominant family represented by 21 species in this assemblage followed by Annonaceae (10 species), Dipterocarpaceae, Sapindaceae and Anacardiaceae (6 species) and Combretaceae, Rubiaceae, and Moraceae (5 species). Fabaceae which appeared in Upper Paleocene became a major constituent of the evergreen forest during Miocene times all along the Himalayan foot hills. The predominance of evergreen and moist deciduous taxa in this fossil assemblage indicates the prevalence of tropical warm humid climate with plenty of rain fall during the Miocene. The present-day distribution of comparable modern species of all the fossils recovered from Koilabas area indicates that they are mostly known to occur in South east Asia, Indo-Malayan and North-east Indian regions, wherever favorable climatic conditions exist. Most of the taxa represented in the fossil assemblage do not occur in the Koilabas area or all along the Himalayan foot-hills of both India and Nepal. This obviously indicates that changes in the climate must have taken place after the deposition of Siwalik sediments in the Koilabas area. Study of the structural features of fossil leaf-impressions suggests that the Koilabas area in the Himalayan foot-hills of western Nepal enjoyed a tropical climate along with plenty of rainfall during the Miocene times. Coexistence /Nearest Living Relative (NLR) method further suggests that the area enjoyed a tropical climate with the Mean Annual Temperature (MAT) 23-30°C and Mean Annual Precipitation (MAP) 2400-3600 mm) during the Miocene.
- Open Access
- 18 February 2019
- Published by Georg Thieme Verlag KG in Drug Research
- Vol. 69 (08) , 419-427
Caveolins; An Assailant or An Ally of Various Cellular Disorders
Caveolae have impressive morphological highlights of the cytomembrane of mammalian cells which involve in wide diversity of cellular functions involving signaling pathways and cholesterol hastening. Caveolin proteins possess a ‘scaffolding’ domain which for caveolin-1 and caveolin-3 appear to act a dominant role in signal regulation through caveolae. Caveolin-1 is treated to be protein in the cytomembrane entrapped with caveolae in endothelial cells and vascular smooth muscle cells which diminish nitric oxide (NO) by fill up the calcium/calmodulin (Ca2+/CaM) confining point of endothelial nitric oxide synthase (eNOS), decrease NO generation produce endothelial dysfunction and atherosclerotic injury development. It is a cholesterol-binding layer protein associated with cell cholesterol transport and also shows cardioprotective action through ischemic preconditioning (IPC) in diabetic and postmenopausal rat heart. Additionally it is ensnared in the procedures of tumorigenesis, prostate disease, and inflammation. The present study in the paper is to explore the structural functionalities of caveolins and their contributory role in CVS disorders and various other diseases.
- 18 February 2019
- Published by Georg Thieme Verlag KG in Drug Research
- Vol. 69 (08) , 419-427
Open AccessCaveolins; An Assailant or An Ally of Various Cellular Disorders
Caveolae have impressive morphological highlights of the cytomembrane of mammalian cells which involve in wide diversity of cellular functions involving signaling pathways and cholesterol hastening. Caveolin proteins possess a ‘scaffolding’ domain which for caveolin-1 and caveolin-3 appear to act a dominant role in signal regulation through caveolae. Caveolin-1 is treated to be protein in the cytomembrane entrapped with caveolae in endothelial cells and vascular smooth muscle cells which diminish nitric oxide (NO) by fill up the calcium/calmodulin (Ca2+/CaM) confining point of endothelial nitric oxide synthase (eNOS), decrease NO generation produce endothelial dysfunction and atherosclerotic injury development. It is a cholesterol-binding layer protein associated with cell cholesterol transport and also shows cardioprotective action through ischemic preconditioning (IPC) in diabetic and postmenopausal rat heart. Additionally it is ensnared in the procedures of tumorigenesis, prostate disease, and inflammation. The present study in the paper is to explore the structural functionalities of caveolins and their contributory role in CVS disorders and various other diseases.